An interventional study of Time-restricted eating and high-intensity interval training in Overweight and Obesity, sponsored by Norwegian University of Science and Technology. Active, not recruiting at 1 site in Norway. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-08-13.
Sponsored by Norwegian University of Science and Technology · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 38 studies in Obesity by Norwegian University of Science and Technology — none open to participants now, 3 under way, none of them phase 3. Obesity · Norwegian University of Science and Technology.
Among the 38 studies in Obesity by Norwegian University of Science and Technology, this one is the 5th largest by planned enrollment of the 37 interventional ones that give a count, is one of 2 that started in 2025, is one of 37 with no phase, and was the 37th registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →None of the 38 studies in Obesity by Norwegian University of Science and Technology is open now. The open studies under Obesity, anywhere →
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 18 Years to 50 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
38 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 2 started in 2025.
This study's planned enrollment of 100 is above the median of 67 across 9,043 interventional studies indexed under Obesity.
Median enrollment 46 across the 37 interventional studies, 405 across the 1 observational. Of the 35 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Norwegian University of Science and Technology is the lead sponsor of 495 studies on the registry; 47 are open to participants now.
2 of the studies in Obesity by Norwegian University of Science and Technology that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07113561Norwegian University of Science and TechnologyEffects of a High-protein Diet and Resistance Training on Fat-mass Loss Maintenance | 2027-01 |
| NCT07036562Norwegian University of Science and TechnologyTime-restricted Eating and High-intensity Interval Training for Metabolic Health in Adults With Overweight/Obesity | 2027-07 |
Add all 2 to your calendar (.ics) → With an account.
Among the 38 studies in Obesity by Norwegian University of Science and Technology, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study will investigate the effects of 12 months periodised time-restricted eating combined with high-intensity interval training compared with a control group on fat mass in adults with overweight/obesity. Participants in the intervention group will complete the intervention remotely and will receive follow-up by telephone. Before randomisation, after 6 months and after 12 months, the investigators will measure the participants' body composition, physical fitness, fasting blood glucose and insulin, blood lipids, and blood pressure. Physical activity, diet, sleep quality, appetite, and adherence to the intervention will also be measured. Secondary sub-analyses of sex differences in the responses to the intervention will be performed.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
This study's planned enrollment of 100 is above the median of 67 across 9,043 interventional studies indexed under Obesity.
Browse Obesity studies →Norwegian University of Science and Technology is the lead sponsor of 495 studies on the registry; 47 are open to participants now.
Compared within Obesity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Overweight. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
12 months of periodised time-restricted eating and high-intensity interval training with digital follow-up
Behavioral: Time-restricted eating and high-intensity interval training
No intervention or follow-up. Habitual lifestyle
1-month intense periods of maximal daily eating window of 10 hours and high-intensity interval training (three weekly, unsupervised, aerobic exercise sessions performed at \> 90 % heart rate maximum), separated by 3-month maintenance periods of time-restricted eating on 5 days per week and minimum 1 HIIT session per week. Each exercise session will last for 33-38 minutes. Participants will receive digital follow-up once weekly during intense periods, and once monthly during maintenance periods. The intervention period will be 12 months in total.
Total fat mass
Change in total fat mass measured with bioelectrical impedance analysis
Time frame: From baseline to after 12 months
Blood glucose
Fasting concentration of plasma glucose
Time frame: From baseline to after 6 months and after 12 months
Total fat mass
Change in total fat mass measured with bioelectrical impedance analysis
Time frame: From baseline to after 6 months
Insulin
Fasting concentration of plasma insulin C-peptide
Time frame: From baseline to after 6 months and after 12 months
Average glucose levels
Glycated haemoglobin (HbA1c)
Time frame: From baseline to after 6 months and after 12 months
Blood cholesterol
Total fasting cholesterol in blood
Time frame: From baseline to after 6 months and after 12 months
LDL-cholesterol
Fasting low-density lipoprotein-cholesterol in blood
Time frame: From baseline to after 6 months and after 12 months
HDL-cholesterol
Fasting high-density lipoprotein-cholesterol in blood
Time frame: From baseline to after 6 months and after 12 months
Triglycerides
Fasting triglycerides in blood
Time frame: From baseline to after 6 months and after 12 months
Cardiorespiratory fitness
Peak oxygen uptake at a maximum effort test, measured in mL/min/kg and L/min
Time frame: From baseline to after 6 months and after 12 months
Insulin sensitivity
Homeostatic model assessment for insulin resistance (HOMA-IR): 1.5 + fasting plasma glucose (mmol/L) x fasting plasma insulin C-peptide (pmol/L)/2800
Time frame: From baseline to after 6 months and after 12 months
Body mass
In kg, estimated with bioelectrical impedance analysis
Time frame: From baseline to after 6 months and after 12 months
Fat-free mass
In kg, estimated with bioelectrical impedance analysis
Time frame: From baseline to after 6 months and after 12 months
Visceral fat area
In cm2, estimated with bioelectrical impedance analysis
Time frame: From baseline to after 6 months and after 12 months
Systolic blood pressure
Average of three measurements during rest in seated position, in mmHg
Time frame: From baseline to after 6 months and after 12 months
Diastolic blood pressure
Average of three measurements during rest in seated position, in mmHg
Time frame: From baseline to after 6 months and after 12 months
Resting heart rate
Average of three measurements during rest in sitting position, in beats/min
Time frame: From baseline to after 6 months and after 12 months
Physical activity levels
International Physical Activity Questionnaire
Time frame: From baseline to after 6 months and after 12 months
Diet intake
3-day diet diaries (two weekdays and one weekend day) with online diet diary.
Time frame: During baseline week, after 4, 13, 30, and 50 weeks.
Sleep quality
The Pittsburgh Sleep Quality Index questionnaire
Time frame: From baseline to after 6 months and after 12 months
Adherence to high-intensity interval training
Number of completed exercise sessions out of those prescribed, in percentage
Time frame: 12 months
Compliance to high-intensity interval training
Exercise intensity measured with pulse sensor. Heart rate percentage of individual heart rate maximum.
Time frame: 12 months
Adherence to time-restricted eating
Average number of days per week a daily eating window of 10 hours or less was achieved
Time frame: During baseline week, after 4, 13, 30, and 50 weeks.
Compliance to time-restricted eating
Average daily eating window, self-reported in hours/day
Time frame: During baseline week, after 4, 13, 30, and 50 weeks.
Perception of intervention and digital follow-up
Qualitative interviews with selected participants to explore barriers and motivators
Time frame: After 12 months
Sex differences
Sub-analyses of sex differences in the effectiveness of the intervention
Time frame: From baseline to after 6 months and after 12 months
Plan to share: Yes — We will make de-identified individual participant data (IPD) collected in the study available to other researchers. We will upload a data set in an open access repository. We will only share IPD that cannot be used to identify individuals.
Supporting information: Study protocol, Statistical analysis plan, Clinical study report, Analytic code
Time frame: The data will become available at the time of publication of the results from the study.
Access criteria: Open access
No publications or documents are linked to this record.
Started Sep 2025 (actual). Primary completion is estimated for Jul 2027, 22 months after the start.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 22 months is close to that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Norwegian University of Science and Technology →